Ad is loading...
MEDCX vs PAEMX
MEDCX vs PAEMX Comparison
Open Charts MEDCX vs PAEMX
MFS Emerging Markets Debt C
Price$11.89
Change+$0.01 (+0.08%)
VolumeN/A
Net Assets6.95B
PIMCO Emerging Markets Bond A
Price$8.38
Change+$0.01 (+0.12%)
VolumeN/A
Net Assets1.67B
MEDCX vs PAEMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
MEDCX vs. PAEMX commentary
May 07, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDCX is a Hold and PAEMX is a Hold.
FUNDAMENTALS
Fundamentals
MEDCX has more cash in the bank: 6.95B vs. PAEMX (1.67B). PAEMX pays higher dividends than MEDCX: PAEMX (6.98) vs MEDCX (5.77). MEDCX was incepted earlier than PAEMX: MEDCX (23 years) vs PAEMX (28 years). MEDCX (1.82) is less costly to investors than PAEMX (1.67). MEDCX is a more actively managed with annual turnover of: 58.00 vs. PAEMX (55.00). MEDCX (1000) and PAEMX (1000) have matching initial minimum investment requirements. PAEMX annual gain was more profitable for investors over the last year : 7.43 vs. MEDCX (5.52). PAEMX return over 5 years is better than : 17.37 vs. MEDCX (11.30).
| MEDCX | PAEMX | MEDCX / PAEMX | |
| Total Expense Ratio | 1.81 | 1.67 | 108% |
| Annual Report Gross Expense Ratio | 1.82 | 1.67 | 109% |
| Fund Existence | 23 years | 28 years | - |
| Gain YTD | 0.829 | 1.526 | 54% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.95B | 1.67B | 417% |
| Annual Yield % from dividends | 5.77 | 6.98 | 83% |
| Returns for 1 year | 5.52 | 7.43 | 74% |
| Returns for 3 years | 14.76 | 18.91 | 78% |
| Returns for 5 years | 11.30 | 17.37 | 65% |
| Returns for 10 years | 20.78 | 33.02 | 63% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSRAX | 8.44 | N/A | N/A |
| Fidelity Advisor Strategic Real Ret A | |||
| UBPSX | 12.76 | N/A | N/A |
| ProFunds UltraLatin America Svc | |||
| FBTAX | 26.04 | N/A | N/A |
| Fidelity Advisor Biotechnology A | |||
| ISTNX | 69.81 | N/A | N/A |
| Macquarie Science and Technology R6 | |||
| VSFIX | 22.17 | -0.21 | -0.94% |
| Federated Hermes Clover Small Value IS | |||